[go: up one dir, main page]

FI883930L - Analogiamenetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaisten valmistamiseksi - Google Patents

Analogiamenetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaisten valmistamiseksi Download PDF

Info

Publication number
FI883930L
FI883930L FI883930A FI883930A FI883930L FI 883930 L FI883930 L FI 883930L FI 883930 A FI883930 A FI 883930A FI 883930 A FI883930 A FI 883930A FI 883930 L FI883930 L FI 883930L
Authority
FI
Finland
Prior art keywords
preparation
therapeutically useful
benzimidazole derivatives
analogous process
useful benzimidazole
Prior art date
Application number
FI883930A
Other languages
English (en)
Swedish (sv)
Other versions
FI883930A0 (fi
FI99013C (fi
FI99013B (fi
Inventor
Klaus Schoellkopf
Helmut Wachtel
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI883930A0 publication Critical patent/FI883930A0/fi
Publication of FI883930L publication Critical patent/FI883930L/fi
Application granted granted Critical
Publication of FI99013B publication Critical patent/FI99013B/fi
Publication of FI99013C publication Critical patent/FI99013C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI883930A 1987-08-25 1988-08-25 Analogiamenetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaisten valmistamiseksi FI99013C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3728695 1987-08-25
DE19873728695 DE3728695A1 (de) 1987-08-25 1987-08-25 Neue benzimidazol-derivate

Publications (4)

Publication Number Publication Date
FI883930A0 FI883930A0 (fi) 1988-08-25
FI883930L true FI883930L (fi) 1989-02-26
FI99013B FI99013B (fi) 1997-06-13
FI99013C FI99013C (fi) 1997-09-25

Family

ID=6334659

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883930A FI99013C (fi) 1987-08-25 1988-08-25 Analogiamenetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaisten valmistamiseksi

Country Status (17)

Country Link
US (1) US4925854A (fi)
EP (1) EP0304789B1 (fi)
JP (1) JP2818170B2 (fi)
AT (1) ATE86982T1 (fi)
AU (1) AU615939B2 (fi)
CA (1) CA1330440C (fi)
DD (1) DD274215A5 (fi)
DE (2) DE3728695A1 (fi)
DK (1) DK169701B1 (fi)
ES (1) ES2054752T3 (fi)
FI (1) FI99013C (fi)
HU (1) HU201746B (fi)
IE (1) IE63283B1 (fi)
IL (1) IL87561A (fi)
NO (1) NO170852C (fi)
PT (1) PT88326B (fi)
ZA (1) ZA886336B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE914003A1 (en) * 1990-11-20 1992-05-20 Astra Pharma Prod Biologically Active Amines
US5371102A (en) * 1992-03-11 1994-12-06 University Of Hawaii Compositions and methods of inhibiting thyroid activity
ZA953311B (en) 1994-04-29 1996-10-24 Lilly Co Eli Non-peptidyl tachykinin receptor antagonists
US5565454A (en) * 1995-05-31 1996-10-15 Ergo Science, Incorporated Method for preventing intervention-associated stenosis and other symptoms associated with stenosis of blood vessels following non-bypass, invasive interventions
TW356468B (en) * 1995-09-15 1999-04-21 Astra Pharma Prod Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same
GB9526511D0 (en) * 1995-12-23 1996-02-28 Astra Pharma Prod Pharmaceutically active compounds
AU2003282510A1 (en) * 2002-10-11 2004-05-04 Bristol-Myers Squibb Company Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents
AU2011383263B2 (en) 2011-12-16 2014-09-04 Colgate-Palmolive Company Color changing compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3813409A (en) * 1972-07-31 1974-05-28 Squibb & Sons Inc Benzimidazolinone compounds
DE3042481A1 (de) * 1980-11-11 1982-06-16 A. Nattermann & Cie GmbH, 5000 Köln (omega)-(2-oxo-benzazolinyl)-alkansaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4367337A (en) * 1981-01-05 1983-01-04 The Sherwin-Williams Company Process for conversion of benzimidazolones to benzotriazoles
AU592765B2 (en) * 1984-08-15 1990-01-25 Schering Aktiengesellschaft New dopamine derivatives, process for their production, and their use as medicinal products
US4554287A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation Antihypertensive 7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones

Also Published As

Publication number Publication date
ATE86982T1 (de) 1993-04-15
NO170852B (no) 1992-09-07
CA1330440C (en) 1994-06-28
NO883776D0 (no) 1988-08-24
EP0304789A2 (de) 1989-03-01
PT88326B (pt) 1995-03-31
JP2818170B2 (ja) 1998-10-30
NO883776L (no) 1989-02-27
DD274215A5 (de) 1989-12-13
US4925854A (en) 1990-05-15
IE63283B1 (en) 1995-04-05
IL87561A (en) 1993-02-21
HU201746B (en) 1990-12-28
DK474288A (da) 1989-02-26
PT88326A (pt) 1989-06-30
JPS6468359A (en) 1989-03-14
HUT49589A (en) 1989-10-30
IE882552L (en) 1989-02-25
FI883930A0 (fi) 1988-08-25
AU615939B2 (en) 1991-10-17
DK474288D0 (da) 1988-08-25
IL87561A0 (en) 1989-01-31
ES2054752T3 (es) 1994-08-16
DE3879322D1 (de) 1993-04-22
AU2149888A (en) 1989-03-02
DK169701B1 (da) 1995-01-16
FI99013C (fi) 1997-09-25
ZA886336B (en) 1989-04-26
EP0304789B1 (de) 1993-03-17
DE3728695A1 (de) 1989-03-09
EP0304789A3 (en) 1989-10-04
FI99013B (fi) 1997-06-13
NO170852C (no) 1992-12-16

Similar Documents

Publication Publication Date Title
FI875660L (fi) Menetelmä terapeuttisesti käyttökelpoisten 5-fenyyli-2-pyrimidinonijohdannaisten valmistamiseksi
FI873205A0 (fi) Menetelmä terapeuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
FI92934B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi
FI881180L (fi) Menetelmä terapeuttisesti käytettävien tetrahydronaftaleenijohdannaisten valmistamiseksi
FI883050L (fi) Menetelmä terapeuttisesti aktiivisten pyranoindolitsinokinoliinijohdannaisten valmistamiseksi
FI883064A (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
FI880941A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten piperatsinyyli-heterosyklisten yhdisteiden valmistamiseksi
FI90346C (fi) Menetelmä terapeuttisesti käyttökelpoisten nor-statiini- ja nor-syklostatiinipolypeptidien valmistamiseksi
FI914905L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten merkaptoasetyyliamidopyrrolo- ja -pyridobentsatsepiinijohdannaisten valmistamiseksi
FI882638L (fi) Menetelmä terapeuttisesti käyttökelpoisten booriaminohappojohdannaisten valmistamiseksi
FI890282A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI874459A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten piperidiinijohdannaisten valmistamiseksi
FI880869A (fi) Menetelmä terapeuttisesti aktiivisten tetratsolijohdannaisten valmistamiseksi
FI921473L (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaisten valmistamiseksi
FI906408L (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-aminopyrimidiini-4-karboksamidijohdannaisten valmistamiseksi
FI93215C (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI883997L (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 2-fenyyli-4-kinoliinikarboksyylihappojen valmistamiseksi
FI884910A (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsopyraanijohdannaisten valmistamiseksi
FI880467A (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI884471A0 (fi) Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi
FI104075B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-karboksitienyylikarbamoyylipyrrolidin-4-yylitiokarbapeneemi-3-karboksyylihappojohdannaisten valmistamiseksi
FI893003L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
FI924642L (fi) Menetelmä terapeuttisesti aktiivisten 3-indolyylitioasetaattijohdannaisten valmistamiseksi
FI882002L (fi) Menetelmä terapeuttisesti aktiivisten fenyylipiperidiinijohdannaisten valmistamiseksi
FI903077A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: SCHERING AKTIENGESELLSCHAFT